Target Interacting Protein Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T39738 | Target Info | |||
Target Name | Cullin-7 (CUL-7) | ||||
Synonyms | KIAA0076 | ||||
Target Type | Literature-reported Target | ||||
Gene Name | CUL7 | ||||
UniProt ID |
Target Interacting Proteins | Top | ||||
---|---|---|---|---|---|
Acyltransferases | [+] 1 Acyltransferases | + | |||
Interacting Protein Name | E3 ubiquitin-protein ligase RBX1 (RBX1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | BA554C12.1; RNF75; ROC1 | ||||
Evidence Score (E-score) | 6 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-Western | [2] | |||
3 | Affinity Capture-Western | [3] | |||
4 | Affinity Capture-Western | [4] | |||
5 | Affinity Capture-Western | [5] | |||
6 | Reconstituted Complex | [2] | |||
Histones | [+] 1 Histones | + | |||
Interacting Protein Name | Histone H2B type 2-E (HIST2H2BE) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | GL105; H2B; H2B.1; H2BFQ; H2BGL105; H2BQ | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [6] | |||
2 | Affinity Capture-Western | [7] | |||
Pore-forming toxins | [+] 1 Pore-forming toxins | + | |||
Interacting Target Name | Cellular tumor antigen p53 (TP53) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tumor suppressor p53; Phosphoprotein p53; P53; Antigen NY-CO-13 | ||||
Evidence Score (E-score) | 10 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [6] | |||
2 | Affinity Capture-Western | [8] | |||
3 | Affinity Capture-Western | [6] | |||
4 | Affinity Capture-Western | [9] | |||
5 | Affinity Capture-Western | [4] | |||
6 | Affinity Capture-Western | [10] | |||
7 | Affinity Capture-Western | [11] | |||
8 | Reconstituted Complex | [12] | |||
9 | Reconstituted Complex | [11] | |||
10 | Yeast two hybrid | [8] | |||
Other proteins | [+] 2 Other proteins | + | |||
Interacting Protein Name | F-box/WD repeat-containing protein 8 (FBXW8) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | FBW6; FBW8; FBX29; FBXO29; FBXW6 | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-Western | [3] | |||
3 | Affinity Capture-Western | [9] | |||
4 | Affinity Capture-Western | [13] | |||
5 | Affinity Capture-Western | [14] | |||
Interacting Protein Name | S-phase kinase-associated protein 1 (SKP1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | EMC19; OCP.II; OCP2; SKP1A; TCEB1L; p19A | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-Western | [2] | |||
3 | Affinity Capture-Western | [13] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Identification of the degradation determinants of insulin receptor substrate 1 for signaling cullin-RING E3 ubiquitin ligase 7-mediated ubiquitination. J Biol Chem. 2012 Nov 23;287(48):40758-66. | ||||
REF 2 | CUL7: A DOC domain-containing cullin selectively binds Skp1.Fbx29 to form an SCF-like complex. Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):16601-6. | ||||
REF 3 | Identification of mutations in CUL7 in 3-M syndrome. Nat Genet. 2005 Oct;37(10):1119-24. | ||||
REF 4 | Cytoplasmic localized ubiquitin ligase cullin 7 binds to p53 and promotes cell growth by antagonizing p53 function. Oncogene. 2006 Aug 3;25(33):4534-48. | ||||
REF 5 | Ankyrin repeats of ANKRA2 recognize a PxLPxL motif on the 3M syndrome protein CCDC8. Structure. 2015 Apr 7;23(4):700-12. | ||||
REF 6 | Identifying biological pathways that underlie primordial short stature using network analysis. J Mol Endocrinol. 2014 Jun;52(3):333-44. | ||||
REF 7 | CRL7SMU1 E3 ligase complex-driven H2B ubiquitylation functions in sister chromatid cohesion by regulating SMC1 expression. J Cell Sci. 2018 Apr 26;131(8). pii: jcs213868. | ||||
REF 8 | Expression of a mutant p193/CUL7 molecule confers resistance to MG132- and etoposide-induced apoptosis independent of p53 or Parc binding. Biochim Biophys Acta. 2007 Mar;1773(3):358-66. | ||||
REF 9 | PARC and CUL7 form atypical cullin RING ligase complexes. Cancer Res. 2007 Mar 1;67(5):2006-14. | ||||
REF 10 | CUL7 is a novel antiapoptotic oncogene. Cancer Res. 2007 Oct 15;67(20):9616-22. | ||||
REF 11 | A novel p53-binding domain in CUL7. Biochem Biophys Res Commun. 2006 Sep 15;348(1):132-8. | ||||
REF 12 | The conserved CPH domains of Cul7 and PARC are protein-protein interaction modules that bind the tetramerization domain of p53. J Biol Chem. 2007 Apr 13;282(15):11300-7. | ||||
REF 13 | Disruption of the Fbxw8 gene results in pre- and postnatal growth retardation in mice. Mol Cell Biol. 2008 Jan;28(2):743-51. | ||||
REF 14 | The CUL7 E3 ubiquitin ligase targets insulin receptor substrate 1 for ubiquitin-dependent degradation. Mol Cell. 2008 May 23;30(4):403-14. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.